Willows Health recruit first patient globally for AstraZeneca Covid Study
We are so pleased that we were the first practice in the world to recruit into the TACKLE AstraZeneca study.
Recruiting the first global patient is a key performance indicator for the life-sciences industry and we are proud to contribute to the Clinical Research Network East Midlands.
We are truly privileged to be able to give our patients the possibility of groundbreaking therapy against Covid 19 . Well done to all staff involved A big Thank you to all our patients who put themselves forward to help with innovative research.
To take part in the study, please click here for further information